What companies are 6826.HK's competitors?

Shanghai Haohai Biological Technology Co., Ltd. (6826.HK)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does 6826.HK compare to its peers?

The peer comparison table on this page shows Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does 6826.HK operate in?

Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

6826.HK

Shanghai Haohai Biological Technology Co., Ltd.

HKSE·Biotechnology · Healthcare

HK$16.50HK$0.33−1.96%

Market capHK$6.63B·Market closed·Jul 22 8:08 AM UTC

Frequently Asked Questions About 6826.HK

What companies are 6826.HK's competitors?: Shanghai Haohai Biological Technology Co., Ltd. (6826.HK)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does 6826.HK compare to its peers?: The peer comparison table on this page shows Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does 6826.HK operate in?: Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

6826.HK

Shanghai Haohai Biological Technology Co., Ltd.

HKSE·Biotechnology · Healthcare

HK$16.50HK$0.33−1.96%

Market capHK$6.63B·Market closed·Jul 22 8:08 AM UTC

Peers


2315.HK	Biocytogen Pharmaceuticals (Beijing) Co., Ltd.	HK$51.90	HK$21.0B
9887.HK	Nanjing Leads Biolabs Co Ltd	HK$66.05	HK$13.1B
1681.HK	Consun Pharmaceutical Group Limited	HK$13.40	HK$11.2B
9997.HK	Kangji Medical Holdings Limited	HK$9.20	HK$10.8B
2142.HK	HBM Holdings Limited	HK$12.60	HK$10.6B
2157.HK	Lepu Biopharma Co., Ltd.	HK$4.86	HK$8.8B
2171.HK	CARsgen Therapeutics Holdings Limited	HK$14.99	HK$8.5B
2186.HK	Luye Pharma Group Ltd.	HK$2.11	HK$8.4B
2256.HK	Abbisko Cayman Limited	HK$10.54	HK$7.6B
9966.HK	Alphamab Oncology	HK$7.58	HK$7.3B

Frequently Asked Questions About 6826.HK

What companies are 6826.HK's competitors?: Shanghai Haohai Biological Technology Co., Ltd. (6826.HK)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does 6826.HK compare to its peers?: The peer comparison table on this page shows Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does 6826.HK operate in?: Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.